BTAI
BTAI
NASDAQ · Biotechnology

Bioxcel Therapeutics Inc

$1.50
+0.13 (+9.49%)
As of Feb 8, 2:22 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 6.05M 5.52M 6.67M
Net Income -605,390 -589,967 -686,380
EPS
Profit Margin -10.0% -10.7% -10.3%
Rev Growth +6.5% -1.7% -4.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 6.86M 5.54M 6.52M
Total Equity 26.63M 24.64M 23.32M
D/E Ratio 0.26 0.23 0.28
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,010,044 -924,468 -1,114,371
Free Cash Flow -597,812 -774,673 -818,976